Development of the composition and production technology of injection medication for intra-articular introduction based on sodiun hyaluronate
Journal Title: Фармацевтичний журнал - Year 2019, Vol 5, Issue 5
Abstract
Osteoarthrosis is the most widespread disease of musculoskeletal system, which leads to different level of disability in 10–30% of cases. The age of the person is one of the key risk factors for the development of such disease. The most effective resolution is a surgery in which joints are replaced, but this method is very risky and expensive especially for elderly people. That is why development of the composition and research in new technological aspects of biotechnological medication is an actual course in pharmacy. The aim of research: development of the composition and production technology of injection solution of hyaluronic acid as sodium hyaluronate for the therapy of degenerate inflammatory disease of articulation. The object of the study is an injection with sodium hyaluronate for intra-articular administration. Evaluation of the test results when choosing the optimal technology for preparing the injection solution was carried out by the visual method (description, transparency), and by the method of rotational viscometry (viscosity). The suitability of the sterilization regime was determined by physicochemical methods (appearance, transparency, viscosity, pH of the solution) and microbiological method (sterility) according to the requirements of SPhU. The quantitative content of sodium hyaluronate was determined by spectrophotometry (SPhU, 2.2.25) using a carbazole reagent. The results of the studies has been developed the optimal composition of the drug based on stabilized sodium hyaluronate by the excipient BDE. The resulting solution in its physical-chemical properties are a clear, highly viscous aqueous solution. The developed composition contains (in %): Sodium hyaluronate with a molecular weight of ~ 2 MDA (in terms of 100% substance) – 1.0; BDE – 0.75; sodium chloride – 0.85; phosphate buffer – up to pH from 5.0 to 8.5; water for injection – up to 100%. The critical parameters of the technological stages for the production of a drug with sodium hyaluronate are determined experimentally. Specific critical parameters are the degassing of a viscous solution, filtration and the conditions of the sterilization mode of the injection solution. It was experimentally established that the optimal parameters for the filtration stage are the use of a Durapore hydrophilic membrane made of polyvinyl difluoride (PVDF), the temperature of the solution is 50 ± 0.5 °C and the use of back pressure mode to reduce the volume wich is filtered per unit time. It was determined that the sterilization mode with saturated steam at a temperature of 121 °C for 8 min is optimal and ensures the quality of the solution in quality criterion of «Sterility». Samples of the experimental series of injection solution, obtained by the developed technology, comply with the requirements of SPhU for drugs for parenteral use according to physical-chemical and biological quality criteria as appearance, transparency, viscosity, pH of the solution, sterility, assay sodium hyaluronate.
Authors and Affiliations
O. O. Saliy, O. V. Los, K. F. Matsiutsia
Keywords
Related Articles
- EP ID EP671119
- DOI 10.32352/0367-3057.5.19.08
- Views 48
- Downloads 0
Optimization of methodology of education, self- education and level knowledge control of pharmacists-interns for «Krok 3. Pharmacy»
Since 2017 exam «Krok 3. Pharmacy» (pilot in 2017–2018) has been included to the system of licensed integrated exams for pharmacists-interns specialty «General Pharmacy». Which introduced some adjustments to the educatio...
Antiinflammatory activity of 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates on carrageenan model of inflammation
In the last decade, high cariesprophylactic efficacy of ammonium hexafluorosilicates, including salts with substituted biologically active ammonium cations, has been demonstrated. Among the promising anti-caries agents a...
Synthesis and anаlgеsic properties of (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine derivatives
In recent years, attention to itself attracted by the problem of pain treatment, which is due to a noticeable increase in patients, especially the able-bodied age. The aim of the study was to synthesize substances with p...
Laboratory preparation and quality control of medicinal composition based on nanosilica and polymethylsiloxane
The prepared ex tempore adsorption composition which consists of nanosilica, polymethylsiloxane, metronidazole and decamethoxin serves as an effective mean for the topical treatment of wounds. The aim of the study was t...
Development of the gel-mask composition with nettle juice intended for telogen effluvium cutaneous application
Taking into account the frequency of telogen effluvium in women, pharmaceutical market demand, a wide range of pharmacological effects of plant biologically active substances, it is important to develop a new medicinal c...